[Publication information] Our comment was published in "The Lancet"
It is said to be one of the most highly regarded medical journals in the world.The Lancet" A comment by Dr. Yoshiko Oshiro (Radiation Oncology Department) was published.
Title of the paper:Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial
Author: Masashi Mizumoto, Yoshiko Oshiro and Hedeyuki Sakurai
雑誌:The Lancet (2024 May 4;403(10438):1749-1750. doi: 10.1016/S0140-6736(24)00358-1.)